Somatostatin 28 is widely used in medical and research fields due to its inhibitory effects on hormone secretion. It is primarily applied in the treatment of various endocrine disorders, such as acromegaly and certain types of tumors, by suppressing the release of growth hormone and other hormones like insulin and glucagon. In clinical settings, it helps manage conditions like gastrointestinal bleeding by reducing blood flow and secretion in the digestive tract. Additionally, it plays a significant role in neuroendocrine research, where it is used to study its effects on neurotransmission and cellular signaling pathways. Its ability to regulate multiple physiological processes makes it a valuable tool in both therapeutic and investigative applications.